Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate

Name: Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate
Published: 2007
License: Public Domain

GlaxoSmithKline · 2007

ClinicalTrials.gov · Datasets · License: Public Domain · 2007

Open Source ↗

diabetes-mellitus insulin-resistance type-2

diabetes mellitus, type 2, total body water, t2dm,, healthy obese,, insulin resistance,, rosiglitazone maleate,, glucose disposal,, hyperinsulinemic-euglycemic clamp,, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate

Related documents